García-Rodríguez José Francisco, Álvarez-Díaz Hortensia, Vilariño-Maneiro Laura, Lorenzo-García María Virginia, Cantón-Blanco Ana, Ordoñez-Barrosa Patricia, Mariño-Callejo Ana Isabel, Sesma-Sánchez Pascual
Infectious Diseases Unit, Internal Medicine Ward, Health Area of Ferrol, SERGAS, La Coruña, Spain.
BMC Infect Dis. 2013 Sep 24;13:445. doi: 10.1186/1471-2334-13-445.
Outside ICUs, CVC-ABSIs epidemiology and the results of strategies for their prevention are not well known. The aim of this study was to investigate the epidemiology and the impact of a multifaceted "bundle" approach in controlling CVC-ABSIs outside ICU.
From 1991 we performed prevalence studies of device and parenteral nutrition use, and prospective surveillance of all episodes of CVC-ABSIs in a 350-bed teaching hospital. CVC-ABSIs incidence/1,000 inpatient-days was calculated. An estimated CVC-ABSIs incidence/1,000 catheter-days was calculated based on the prevalence rates of catheter use and the total number of inpatient-days in each year. On november 2008, an education programme was instituted for care of catheter lines: reinforcing instructions in aseptic insertion technique, after care and hand-washing; in order to assess the adherence to these measures the quantity of alcohol-based hand-rub consumption/1,000 patient-days was quoted in litres. From January 2009, a checklist intervention for CVC insertion in ICU was started: hand hygiene, using full barrier precautions, cleaning the skin with alcoholic chlorhexidine, avoiding femoral access and removing unnecessary catheters. Compliance with the central line insertion checklist was measured by real-time audits and was achieved in 80% of cases.
Prevalence of use of CVC and parenteral nutrition was similar throughout the study. We followed-up 309 CVC-ABSIs cases. Estimated CVC-ABSIs rate progressively increased to 15.1/1,000 catheter-days in 2008 (0.36/1,000 inpatient-days). After the intervention, the alcohol-based hand-rub consumption increased slightly and estimated CVC-ABSIs rate fell to 10.1 /1,000 catheter-days in last three years (0.19/1,000 inpatient-days), showing a 32.9% decrease. The infection rates achieved were lower in Internal Medicine wards: decreased from 14.1/1,000 catheter-days (0.17/patient-days) in 2008 to 5.2/1,000 catheter-days (0.05/1,000 inpatient-days) in last three years, showing a 63.1% decrease. In 2009, the estimated CVC-ABSIs incidence rate was significantly lower in the Internal Medicine ward compared to the Surgery ward: rate ratio (RR) = 0.14, 95%CI: 0.03-0.60), and within the Internal Medicine ward, the estimated CVC-ABSIs incidence rate was significantly lower in 2009 compared to 2008 (RR = 0.20, 95%CI: 0.04-0.91).
The rate of CVC-ABSIs increased outside-ICU, and the implementation of multifaceted infection control programme decreased their clinical impact.
在重症监护病房(ICU)之外,中心静脉导管相关血流感染(CVC-ABSIs)的流行病学情况以及预防策略的效果尚不清楚。本研究旨在调查ICU以外环境中CVC-ABSIs的流行病学情况以及多方面“集束化”方法在控制CVC-ABSIs方面的影响。
自1991年起,我们在一家拥有350张床位的教学医院开展了设备及肠外营养使用情况的患病率研究,并对所有CVC-ABSIs事件进行前瞻性监测。计算CVC-ABSIs发病率/每1000住院日。根据每年导管使用的患病率和住院日总数计算估计的CVC-ABSIs发病率/每1000导管日。2008年11月,启动了一项关于导管护理的教育计划:强化无菌插入技术、导管维护及洗手方面的指导;为评估对这些措施的依从性,以升为单位记录每1000患者日酒精类手消毒剂的消耗量。从2009年1月起,开始在ICU实施CVC插入的核对表干预措施:手部卫生、采用全面屏障防护措施、用氯己定酒精清洁皮肤、避免股静脉置管以及拔除不必要的导管。通过实时审核来衡量对中心静脉导管插入核对表的依从性,80%的病例达到了要求。
在整个研究过程中,CVC和肠外营养的使用患病率相似。我们对309例CVC-ABSIs病例进行了随访。估计的CVC-ABSIs发生率在2008年逐渐上升至15.1/每1000导管日(0.36/每1000住院日)。干预后,酒精类手消毒剂的消耗量略有增加,估计的CVC-ABSIs发生率在过去三年降至10.1/每1000导管日(0.19/每1000住院日),下降了32.9%。内科病房实现的感染率较低:从2008年的14.1/每1000导管日(0.17/每患者日)降至过去三年的5.2/每1000导管日(0.05/每1000住院日),下降了(63.1%)。2009年,内科病房估计的CVC-ABSIs发病率显著低于外科病房:率比(RR)=0.14,95%置信区间(CI):0.03 - 0.60),在内科病房内,2009年估计的CVC-ABSIs发病率显著低于2008年(RR = 0.20,95%CI:0.04 - 0.91)。
ICU以外环境中CVC-ABSIs的发生率有所上升,多方面感染控制计划的实施降低了其对临床的影响。